ViroPharma Incorporated Announces Completion of Offering
12 déc. 2005 12h50 HE
|
ViroPharma Incorporated
EXTON, Pa., Dec. 12, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the completion of its previously announced underwritten public offering of 10,350,000 shares of newly...
ViroPharma Incorporated Announces Exercise of Option to Purchase Additional Securities
09 déc. 2005 07h32 HE
|
ViroPharma Incorporated
EXTON, Pa., Dec. 9, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the underwriters of its recent public offering of 9,000,000 shares of common stock have exercised in...
Recent Key Publications Describe Evolving Epidemic of Severe Clostridium difficile-Associated Disease
08 déc. 2005 15h35 HE
|
ViroPharma Incorporated
EXTON, Pa., Dec. 8, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that The New England Journal of Medicine (NEJM) and the Center for Disease Control and Prevention's (CDC)...
ViroPharma Incorporated Prices Public Offering of Common Stock
07 déc. 2005 06h35 HE
|
ViroPharma Incorporated
EXTON, Pa., Dec. 7, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the pricing of an underwritten public offering of 9,000,000 shares of newly issued common stock at $16.75...
ViroPharma Incorporated Announces Public Offering of Common Stock
28 nov. 2005 16h01 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 28, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it plans to offer 7,000,000 shares of its common stock in a public offering. ViroPharma also...
ViroPharma Completes Enrollment in Phase 2 Clinical Study of Maribavir in Bone Marrow Transplant Patients
28 nov. 2005 11h06 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 28, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has completed enrollment in its Phase 2 clinical study for maribavir, an oral antiviral drug...
ViroPharma to Present at the Lazard Capital Markets Life Sciences Conference
22 nov. 2005 15h13 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 22, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the Lazard Capital Markets Life Sciences Conference, at 1:30 P.M. EST on...
ViroPharma Selected for NASDAQ Biotechnology Index
14 nov. 2005 09h18 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 14, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has been selected to become a member of the NASDAQ Biotechnology Index(R). ViroPharma's...
ViroPharma to Present at the 2005 Credit Suisse First Boston Health Care Conference
11 nov. 2005 14h23 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 11, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at the 2005 Credit Suisse First Boston Health Care Conference, at 3:30 p.m. MST...
ViroPharma to Host Conference Call to Discuss Clinical Results of HCV-796
10 nov. 2005 12h47 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the company will host a conference call and live audio webcast today at 4:30 p.m. to discuss the...